Imaging Technology

SEPTEMBER 20, 2023

a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for cancer detection and treatment, announced an exclusive licensing agreement for RefleXion to develop and commercialize a specific 3BP molecule to direct its SCINTIX biology-guided radiotherapy.

Pharmaceutical 97

Pharmaceutical Radiopharmaceuticals Radiation Diagnostic 97

Imaging Technology

JUNE 15, 2023

The clinical trial will use this investigational radiopharmaceutical to help understand if patients have CD8+ T cells in their tumors and will, therefore, be more likely to respond to immune checkpoint inhibitors, the main class of immunotherapies currently approved for use.

Radiopharmaceuticals 87

Radiopharmaceuticals Pharmaceutical Nuclear Medicine PET Scan 87

Imaging Technology

SEPTEMBER 8, 2023

milla1cf Fri, 09/08/2023 - 16:25 September 8, 2023 — Positron Corporation , a leading molecular imaging medical device company, is pleased to announce that the Company will begin its clinical study of its Affinity PET-CT imaging device with Ochsner Clinic Foundation in New Orleans, LA. on September 18, 2023.

Clinic 95

Clinic Radiopharmaceuticals Medical Device IT 95

Imaging Technology

FEBRUARY 21, 2024

milla1cf Wed, 02/21/2024 - 18:58 February 21, 2024 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, is pleased to share the publication of promising early clinical data with 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1

Clinic 81

Clinic Radiopharmaceuticals Nuclear Medicine Hospital 81

Imaging Technology

JANUARY 5, 2024

milla1cf Fri, 01/05/2024 - 11:32 January 5, 2024 — NorthStar Medical Radioisotopes, LLC , a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc. Chief Executive Officer of NorthStar Medical Radioisotopes.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Nuclear Medicine Pharmaceutical 52

AuntMinnie

APRIL 4, 2024

Life Molecular Imaging (LMI) and Sofie Biosciences have begun offering the Neuraceq ( florbetaben F-18) PET radiotracer produced at Sofie's radiopharmaceutical manufacturing site in Cleveland, Ohio. With this expansion, LMI continues driving commercial sales of Neuraceq around the U.S.

Radiopharmaceuticals 85

Radiopharmaceuticals Imaging Disease Diagnostic 85

Imaging Technology

NOVEMBER 26, 2023

TeleDaaS specializes in delivering clinical-grade, precision-based dosimetry analysis and treatment plans to clinical research organizations (CROs) and pharmaceutical manufacturers. Radiopharmaceuticals are revolutionizing modern cancer treatment and precision dosimetry is a crucial component of this advanced therapy.

Clinic 54

Clinic Radiopharmaceuticals Radiosensitivity Pharmaceutical 54

Imaging Technology

AUGUST 29, 2023

Administration of the therapeutic dose took place as part of an ongoing Phase I/IIa theranostic clinical trial conducted by Clarity Pharmaceuticals to investigate the safety and efficacy of Cu-67 SARTATE in pediatric patients with high-risk neuroblastoma.

Pharmaceutical 75

Pharmaceutical Radiopharmaceuticals Clinic Medical 75

AuntMinnie

JUNE 5, 2024

NorthStar Medical Radioisotopes has completed a cleanroom facility at its campus in Beloit, WI, to support batch production of radiopharmaceuticals for research and treatment. The cleanroom at NorthStar's campus in Beloit, WI.

Radiopharmaceuticals 52

Radiopharmaceuticals Clinic Medical IT 52

TTG Imaging Solutions

AUGUST 1, 2023

Martin Shirley was appointed the role of TTG Imaging Solutions Executive Vice President Sales, Marketing & Clinical Operations in April of 2023 as part of TTG Imaging Solutions acquisition of Digirad Health, Inc and its subsidiaries Digirad Diagnostic Imaging, Inc and Digirad Imaging Solution, Inc.

Nuclear Medicine 40

Nuclear Medicine Clinic Radiopharmaceuticals Diagnostic Imaging 40

TTG Imaging Solutions

AUGUST 1, 2023

Martin Shirley was appointed the role of TTG Imaging Solutions Executive Vice President Sales, Marketing & Clinical Operations in April of 2023 as part of TTG Imaging Solutions acquisition of Digirad Health, Inc and its subsidiaries Digirad Diagnostic Imaging, Inc and Digirad Imaging Solution, Inc.

Nuclear Medicine 40

Nuclear Medicine Clinic Radiopharmaceuticals Diagnostic Imaging 40

AuntMinnie

JUNE 19, 2024

Voximetry now offers nuclear medicine dosimetry technology as a remote service, with its recent launch of RPT Dosimetry Clinical Services. Incorporating radiopharmaceutical therapy dosimetry typically requires advanced, in-house software, and a trained physics staff, Voximetry said.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Clinic Imaging 52

AuntMinnie

MAY 30, 2023

Read more on AuntMinnie.com Related Reading: Blue Earth touts clinical results Blue Earth highlights results from PET tracer trial PET tracer shows promise in imaging of brain tumors Blue Earth touts PSMA radiotracer study Blue Earth moves toward U.K. prostate radiopharmaceutical licensing

Radiopharmaceuticals 52

Radiopharmaceuticals Imaging Diagnostic Clinic 52

Imaging Technology

JULY 28, 2023

It is the first and only FDA-approved, PSMA-targeted imaging agent developed with proprietary radiohybrid (rh) technology. We believe it further validates the clinical utility of POSLUMA in patients with newly diagnosed or recurrent prostate cancer, and can help expand patient access. POSLUMA was approved by the U.S.

Clinic 84

Clinic Diagnostic Radiopharmaceuticals Radiation 84

Imaging Technology

JUNE 11, 2024

She will also raise awareness of nuclear medicine’s value to clinical colleagues and patients and will be laser-focused on breaking down barriers to radiopharmaceutical availability, reimbursement, affordability, and funding. SNMMI introduced a new slate of officers during its 2024 Annual Meeting, held June 8-11 in Toronto.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Patient Care Medical 52

Imaging Technology

DECEMBER 12, 2023

milla1cf Tue, 12/12/2023 - 10:00 December 12, 2023 — IBA , a world leader in particle accelerator technology and of radiopharmaceutical production solutions is pleased to announce the start of the installation of a Cyclone 30XP in Poland. Beyond At-211, IBA is also pioneering novel accelerator applications for other theranostic isotopes.

Radiopharmaceuticals 111

Radiopharmaceuticals Nuclear Medicine Clinic IT 111

Imaging Technology

JUNE 7, 2024

milla1cf Fri, 06/07/2024 - 14:57 June 7, 2024 — Shine Technologies, LLC , a pioneer in next-generation fusion-based technology, today announced a new partnership with Blue Earth Therapeutics , a Bracco company and recognized leader in the development of innovative radiopharmaceuticals. Statistically, approximately 12.9%

IT 85

IT Radiopharmaceuticals Clinic Diagnose 85

AuntMinnie

JUNE 20, 2024

F-18 fluorocholine (FCH) PET/CT could be a first-line technique over technetium-99m sestamibi (Tc-99m MIBI) SPECT/CT for imaging parathyroid tumors prior to surgery, according to a study published June 20 in JAMA Otolaryngology-Head & Neck Surgery. No complications occurred. The full study is available here.

Radiopharmaceuticals 105

Radiopharmaceuticals Radiation Imaging Clinic 105

AuntMinnie

JUNE 10, 2024

Evans, PhD, has been named the 2024 recipient of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Sam Gambhir Trailblazer Award. He completed a postdoctoral fellowship in molecular imaging at Memorial Sloan Kettering Cancer Center. He will be honored at the SNMMI's annual meeting in Toronto.

Nuclear Medicine 40

Nuclear Medicine Radiopharmaceuticals Pharmaceutical Clinic 40

AuntMinnie

JUNE 11, 2024

TORONTO – The radiopharmaceutical Pluvicto improves progression-free survival in patients with metastatic prostate cancer who haven’t undergone taxane therapy, according to research presented at the SNMMI meeting. Oliver Sartor, MD The study, which was awarded SNMMI’s Abstract of the Year award, shared data from the phase III PSMAfore trial.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiograph Radiographer 122

TTG Imaging Solutions

MAY 5, 2023

Enhances TTG’s continued commitment to offer a full spectrum of high-quality and cost-effective service solutions in the cardiology and radiation oncology markets PITTSBURGH, PA (May 5, 2023) – TTG Imaging Solutions, LLC (TTG) announced today the acquisition of Digirad Health, Inc., headquartered in Suwanee, GA. Digirad Health, Inc.

Imaging 52

Imaging Radiopharmaceuticals Radiation Oncology Nuclear Medicine 52

TTG Imaging Solutions

FEBRUARY 17, 2022

Imaging Conference & Expo: February 20 – 22, 2022 TTG Imaging Solutions will be exhibiting at the Imaging Conference & Expo in Napa, CA. Be sure to visit us at booth #304 Monday, February 21 and Tuesday, February 22 to discover solutions for equipment, nationwide service, parts, and clinical support.

Nuclear Medicine 52

Nuclear Medicine Imaging Radiopharmaceuticals Diagnostic Imaging 52

Imaging Technology

JANUARY 12, 2024

“We are grateful that CMS recognizes the potential of our SCINTIX therapy for patients with all stages of indicated cancers and, with this decision, has addressed provider payment as a barrier to clinical adoption,” continued Powell. Patient treatments also began at several clinical sites in 2023. 1, 2024, to describe SCINTIX therapy.

Radiopharmaceuticals 100

Radiopharmaceuticals Radiation Medicare Clinic 100

Imaging Technology

MAY 30, 2023

milla1cf Tue, 05/30/2023 - 19:49 May 30, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals , today announced U.S. It is the first and only FDA-approved, PSMA-targeted imaging agent developed with proprietary radiohybrid (rh) technology.

Diagnostic 75

Diagnostic Imaging Radiopharmaceuticals Diagnostic Imaging 75

AuntMinnie

MARCH 25, 2024

PET/CT is poised to become a key tool for imaging the coronary arteries – a clinical imaging exam that can reveal early warning signs of fatal conditions when patients present with symptoms of chest pain, experts say. The game-changer could be the pending U.S. approval of new PET radiotracers, such as F-18 flurpiridaz , he said.

Nuclear Medicine 128

Nuclear Medicine Radiopharmaceuticals Disease Radiation 128

Imaging Technology

AUGUST 31, 2023

milla1cf Thu, 08/31/2023 - 15:50 August 31, 2023 — NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals, and Curadh MTR Inc. Ac-225 for use in radiopharmaceutical therapy (RPT). actinium-225 (Ac-225). “As a company at the forefront of U.S.

Medical 91

Medical Radiopharmaceuticals Pharmaceutical Radiation 91

AuntMinnie

JUNE 27, 2023

Read more on AuntMinnie.com Related Reading: FDA approves new PET tracer for prostate cancer imaging Blue Earth touts clinical results PET tracer shows promise in imaging of brain tumors Blue Earth touts PSMA radiotracer study Blue Earth moves toward U.K. prostate radiopharmaceutical licensing

Radiopharmaceuticals 52

Radiopharmaceuticals Diagnostic Clinic Imaging 52

Imaging Technology

MAY 14, 2024

milla1cf Tue, 05/14/2024 - 12:45 May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on their 40-year history of clinical and research collaboration. This alliance will help UH expand patient access and transform cancer care from discovery to recovery.

Hospital 103

Hospital Magnetic Resonance Imaging Radiopharmaceuticals Disease 103

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

Imaging Technology

MAY 23, 2023

milla1cf Tue, 05/23/2023 - 11:36 May 23, 2023 — More than 9 in 10 radiation oncologists report that their practices face clinical staff shortages , according to a new national survey from the American Society for Radiation Oncology ( ASTRO ). Radiation oncologists from across the country are in Washington, D.C. in the past three decades.

Radiation Oncology 69

Radiation Oncology Radiation Clinic Medicare 69

AuntMinnie

JANUARY 11, 2024

RefleXion said while other technologies use anatomical images to guide radiotherapy delivery, Scintix therapy is the only radiotherapy to use emissions from cancer cells. These are created by injecting the patient with a radiopharmaceutical to deliver a radiation dose that targets the cancer itself.

Radiopharmaceuticals 52

Radiopharmaceuticals Medicare Radiation Hospital 52

Imaging Technology

AUGUST 28, 2023

The companies will work together to increase near-term production of 225Ac [1] to support ongoing clinical trials and to ensure the large-scale supply of the radioisotope in the long term, addressing growing global demand. Whilst there is high demand, there is a scarcity of 225Ac.

Radiopharmaceuticals 94

Radiopharmaceuticals Pharmaceutical Clinic Medical 94

Imaging Technology

JUNE 21, 2023

POSLUMA (formerly referred to as to as 18F-rhPSMA-7.3 ) is an optimized, high-affinity radiohybrid (rh) Prostate-Specific Membrane Antigen (PSMA)-targeted PET imaging agent. Additional PETNET sites are expected to manufacture POSLUMA before the end of the summer. “We Gauden , D.Phil., Chief Executive Officer of Blue Earth Diagnostics Ltd.

Diagnostic 75

Diagnostic Radiopharmaceuticals Imaging Medicare 75

Imaging Technology

JULY 5, 2023

Ac-225 is a high energy alpha-emitting radioisotope of increasing interest for clinical studies investigating the use of targeted radiopharmaceutical therapy, which combines select molecules with therapeutic radioisotopes to directly target and deliver therapeutic doses of radiation to destroy cancer cells in patients with serious disease.

Medical 63

Medical Radiopharmaceuticals Pharmaceutical Radiation 63

Open Medscience

MAY 14, 2024

Positron Emission Tomography Imaging has advanced with cutting-edge technologies, enhancing diagnostic accuracy and expanding clinical applications dramatically. The post Breakthroughs in Positron Emission Tomography Imaging appeared first on Open MedScience.

Imaging 52

Imaging Diagnostic Clinic Nuclear Medicine 52

TTG Imaging Solutions

MAY 26, 2022

We have expanded our pharmacy presence both physically and through strategic partnerships while also expanding our footprint of clinical technologists in the regions that business unit serves. About TTG Imaging Solutions TTG Imaging Solutions provides a breadth of product and service offerings with its End-to-End Solution.

Nuclear Medicine 52

Nuclear Medicine Imaging Radiopharmaceuticals Medical Imaging 52

TTG Imaging Solutions

DECEMBER 26, 2021

PITTSBURGH, PA (December 27, 2021) – TTG Imaging Solutions, LLC (TTG) announced today a partnership with Sentinel Capital Partners, a private equity firm that invests in promising midmarket companies. Mastarone continued, “It was our goal to find a partner who shared our vision of TTG within the broader medical imaging industry.

Imaging 52

Imaging Radiopharmaceuticals Medical Imaging Medical 52